Company Filing History:
Years Active: 2012
Title: Gerd Bayer - Innovator in Stent Coating Technology
Introduction
Gerd Bayer is a notable inventor based in Erlangen, Germany. He has made significant contributions to the field of medical technology, particularly in the development of stent coating methods. His innovative approach aims to enhance the performance and functionality of stents used in various medical procedures.
Latest Patents
Gerd Bayer holds a patent for a method of coating a stent with a polysaccharide layer. This invention focuses on improving the adhesion capacity of the polysaccharide layer on the substrate surface of the implant. The patent outlines methods that involve covalent bonding of a non-crosslinked hyaluronic acid to the stent's surface, resulting in a functionalized hyaluronic acid layer that is crosslinked for enhanced performance.
Career Highlights
Bayer is associated with Biotronik Mess-und Therapiegeräte GmbH & Co., a company known for its advancements in medical technology. His work has contributed to the development of innovative solutions that improve patient outcomes in cardiovascular treatments.
Collaborations
Gerd Bayer has collaborated with notable colleagues, including Markus Nagel and Alexander Borck. Their combined expertise has furthered advancements in stent technology and medical device innovation.
Conclusion
Gerd Bayer's contributions to stent coating technology exemplify the impact of innovation in the medical field. His patented methods enhance the functionality of stents, ultimately benefiting patient care and treatment outcomes.